ABTHER-150MG INJ EACH
Abther 150 Injection is a potent antimalarial medication formulated for the treatment of severe and complicated malaria, particularly cases caused by Plasmodium falciparum. With α-β Arteether as its active ingredient, this prescription-only medicine is designed for intramuscular administration, delivering rapid therapeutic action in critical cases. Abther 150 is manufactured by Indasi Lifescience Pvt Ltd in India and marketed by Greenlife Pharmaceutical Limited.
Product Overview
Product Name: Abther 150 Injection
Active Ingredient: α-β Arteether
Strength: 150 mg/2 mL
Dosage Form: Solution for injection (oily)
Route of Administration: Intramuscular (IM)
ATC Code: P01BE
Product Category: Drugs
Marketing Category: Prescription-only Medicine (POM)
Pack Size: 2 mL x 3’s (in amber glass ampoules)
Product Description: Colourless to pale yellow oily solution, filled and sealed in 2-mL amber glass ampoules
Regulatory and Manufacturer Information
Applicant Name: Greenlife Pharmaceutical Limited
NRN: B4-7301
Status: Active
Approval Date: March 28, 2023
Manufacturer: Indasi Lifescience Pvt Ltd
Manufacturer Country: India
Composition
Each 2 mL ampoule contains:
Alpha Beta Arteether: 150 mg
Arachis Oil BP: Quantity sufficient
Clinical Uses
Abther 150 Injection is indicated for:
Severe and Complicated Malaria: Especially suitable for rapidly treating cases of Plasmodium falciparum malaria, including drug-resistant strains.
Fast Parasite Clearance: Arteether is an artemisinin derivative that quickly reduces malarial parasite loads, helping to alleviate symptoms and prevent complications.
Product Description
Abther 150 Injection is supplied as a clear, colourless to pale yellow oily solution. Each dose is filled and sealed in a 2-mL amber glass ampoule, with three ampoules per pack. The amber glass protects the medication from light, ensuring product stability and efficacy.
